Characteristics | circSTX6 expression | Â | miR-449b-5p expression | Â | ||
---|---|---|---|---|---|---|
Low expression (n = 49) | High expression (n = 48) | P value | Low expression (n = 49) | High expression (n = 48) | P value | |
Gender | Â | Â | 0.941 | Â | Â | 0.617 |
   Male | 32 | 31 |  | 33 | 30 |  |
   Female | 17 | 17 |  | 16 | 18 |  |
Age(years) | Â | Â | 0.667 | Â | Â | 0.162 |
   < 60 | 12 | 10 |  | 14 | 8 |  |
   ≥ 60 | 37 | 38 |  | 35 | 40 |  |
Location | Â | Â | 0.437 | Â | Â | 0.437 |
   Head | 30 | 33 |  | 30 | 33 |  |
   Body + tail | 19 | 15 |  | 19 | 15 |  |
Tumor differentiation | Â | Â | 0.008** | Â | Â | 0.584 |
   G1 + G2 | 25 | 12 |  | 20 | 17 |  |
   G3 | 24 | 36 |  | 29 | 31 |  |
TNM stage | Â | Â | 0.264 | Â | Â | 0.019* |
   I + II | 22 | 27 |  | 19 | 30 |  |
   III + IV | 27 | 21 |  | 30 | 18 |  |
T stage | Â | Â | 0.352 | Â | Â | 0.01* |
   T1 + T2 | 25 | 29 |  | 21 | 33 |  |
   T3 + T4 | 24 | 19 |  | 28 | 15 |  |
N stage | Â | Â | 0.019* | Â | Â | 0.752 |
   N0 | 28 | 16 |  | 23 | 21 |  |
   N1 + N2 | 21 | 32 |  | 26 | 27 |  |
Nerve invasion | Â | Â | 0.102 | Â | Â | 0.765 |
   No | 8 | 2 |  | 6 | 4 |  |
   Yes | 41 | 46 |  | 43 | 44 |  |
Major vascular invasion | Â | Â | 0.612 | Â | Â | 0.068 |
   No | 14 | 16 |  | 11 | 19 |  |
   Yes | 35 | 32 |  | 38 | 29 |  |
Serum CA19-9(U/ml) | Â | Â | 0.424 | Â | Â | 0.812 |
   < 37 | 9 | 6 |  | 8 | 7 |  |
   ≥ 37 | 40 | 42 |  | 41 | 41 |  |